| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8775743 | Urology | 2018 | 26 Pages |
Abstract
Warfarin use poses the greatest risk for hematuria but is unlikely to cause major hematuria, whereas novel antithrombotic agents are more commonly associated with major hematuria. This review further characterizes the risk profile of antithrombotic agents and associated hematuria to equip clinicians with knowledge to choose an appropriate antithrombotic agent in patients with high-risk hematuria.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Nikita R. Bhatt, Niall F. Davis, William J. Nolan, Robert J. Flynn, Ted McDermott, Arun Z. Thomas, Rustom P. Manecksha,